Page 39 - Read Online
P. 39

Kaya et al. Neuroimmunol Neuroinflammation 2019;6:5  I  http://dx.doi.org/10.20517/2347-8659.2018.70               Page 13 of 15


                   1989;239:19-29.
               3.   Green BA, Klose JK, Goldberg ML. Clinical and research considerations in spinal cord injury. In: Becker DP, editor. Central nervous
                   system trauma status report. Washington, DC: National Institutes of Health; 1985. pp. 341-68.
               4.   Green BA, Magana I. Spinal injury pain. In: Long DM, editor. Current therapy in neurological surgery. Philadelphia: BC Decker; 1989.
                   pp. 294-7.
               5.   Woodruff BA, Baron RCA. Description of nonfatal spinal cord injury using a hospital-based registry. Am J Prev Med 1994;10:10-4.
               6.   Young JS, Northrup NE. Statistical information pertaining to some of the most commonly asked questions about spinal cord injury.
                   Spinal Cord Injury Digest 1979;1:11.
               7.   Green BA, Eismont FJ, O’Heir JT. Pre-hospital management of spinal cord injuries, Paraplegia 1987;25:229-38.
               8.   Ray SK, Hogan EL, Banik NL. Calpain in the pathophysiology of spinal cord injury: Neuroprotection with calpain inhibitors, Brain Res
                   Rev 2003;42:169-85.
               9.   Rossignol S, Schwab M, Schwartz M, Fehlings G. Spinal cord injury: time to move? J Neurosci 2007;27:11782-92.
               10.  Huang H, Liu H, Yan R, Hu M. PI3K/Akt and ERK/MAPK signaling promote different aspects of neuron survival and axonal regrowth
                   following, rat facial nerve axotomy. Neurochem Res 2017;42:3515-24.
               11.  Xu B, Chen S, Luo Y, Chen Z, Liu L, et al. Calcium signaling is involved in cadmium-induced neuronal apoptosis via induction of
                   reactive oxygen species and activation of MAPK/mTOR network. PLoS One 2011;6:e19052.
               12.  McAndrew CW, Gastwirt RF, Donoghue DJ. The atypical CDK activator Spy1 regulates the intrinsic DNA damage response and is
                   dependent upon p53 to inhibit apoptosis. Cell Cycle 2009;8:66-75.
               13.  Yıldız Ünal A, Korulu Ş, Karabay A. SpeedyRINGO inhibits calpain-directed apoptosis in neurons, J Alzheimers Dis 2012;31:779-91.
               14.  Wang XD, Zhu MW, Shan D, Wang SY, Yin X, et al. Spy1, a unique cell cycle regulator, alters viability in ALS motor neurons and cell
                   lines in response to mutant SOD1-induced DNA damage. DNA Repair (Amst) 2019;74:51-62.
               15.  Huang Y, Liu Y, Chen Y, Yu X, Yang J, et al. Peripheral nerve lesion induces an up-regulation of Spy1 in rat spinal cord. Cell Mol
                   Neurobiol 2009;29:403-11.
               16.  Golipour A, Myers D, Seagroves T, Murphy D, Evan GI, et al. The Spy1/RINGO family represents a novel mechanism regulating
                   mammary growth and tumorigenesis. Cancer Res 2008;68:3591-600.
               17.  Liu ML, Cheng YM, Jia MC. LM23 is essential for spermatogenesis in Rattus norvegicus. Front Biosci 2010;2:187-94.
               18.  Liu P, Begley M, Michowski W, Inuzuka H, Ginzberg M, et al. Cell-cycle-regulated activation of Akt kinase by phosphorylation at its
                   carboxyl terminus. Nature 2014;508:541-5.
               19.  Platt SR. The role of glutamate in central nervous system health and disease-a review. Vet J 2007;173:278-86.
               20.  Gagliardi RJ. Neuroprotection, excitotoxicity and NMDA antagonists. Arq Neuropsiquiatr 2000;58:583-8.
               21.  Berliocchi L, Bano D, Nicotera P. Ca2+ signals and death programmes in neurons. Philos Trans R Soc Lond B Biol Sci 2005;360:2255-8.
               22.  Wong PC, Cai H, Borchelt DR, Price DL. Genetically engineered mouse models of neurodegenerative diseases. Nat Neurosci
                   2002;5:633-9.
               23.  Anderson CNG, Tolkovsky AM. Role for MAPK/ERK in sympathetic neuron survival: protection against a p53-Dependent, JNK-
                   Independent Induction of Apoptosis by Cytosine Arabinoside. J Neurosci 1999;19:664-73.
               24.  Institute of Medicine. Spinal cord injury: progress, promise, and priorities. Washington, DC: The National Academies Press; 2005.
               25.  Choi DW. Methods for antagonizing glutamate neurotoxicity. Cerebrovasc Brain Metab Rev 1990;2:105-14732.
               26.  Du S, Rubin A, Klepper S, Barrett C, Kim YC, et al. Calcium influx and activation of Calpain I mediate acute reactive gliosis in injured
                   spinal cord. Exp Neurol 1999;157:96-105.
               27.  Beirowski B, Adalbert R, Wagner D, Grumme DS, Addicks K, et al. The progressive nature of Wallerian degeneration in wild-type and
                   slow Wallerian degeneration (WldS) nerves. BMC Neurosci 2005;6:6.
               28.  Emery E, Aldana P, Bunge MB, Puckett W, Srinivasan A, et al. Apoptosis after traumatic human spinal cord injury. J Neurosurg
                   1998;89:911-20.
               29.  Mizuno Y, Mochizuki H, Sugita Y, Goto K. Apoptosis in neurodegenerative disorders. Intern Med 1998;37:192-3.
               30.  Das A, Smith JA, Gibson C, Varma AK, Ray SK, et al. Estrogen receptor agonists and estrogen attenuate TNF-alpha-induced apoptosis
                   in VSC4.1 motoneurons. J Endocrinol 2011;208:171-82.
               31.  Samantaray S, Sribnick EA, Das A, Knaryan VH, Matzelle D, et al. Melatonin attenuates calpain upregulation, axonal damage and
                   neuronal death in spinal cord injury in rats. J Pineal Res 2008;44:348-57.
               32.  Das A, McDowell M, Pava MJ, Smith JA, Reiter RJ, et al. The inhibition of apoptosis by melatonin in VSC4.1 motoneurons exposed to
                   oxidative stress, glutamate excitotoxicity, or TNF-alpha toxicity involves membrane melatonin receptors. J Pineal Res 2010;48:157-69.
               33.  Ray SK, Hogan EL, Banik NL. Calpain in the pathophysiology of spinal cord injury: neuroprotection with calpain inhibitors. Brain Res
                   Rev 2003;42:169-85.
               34.  Samantaray S, Sribnick EA, Das A, Thakore NP, Matzelle D, et al. Neuroprotective efficacy of estrogen in experimental spinal cord
                   injury in rats. Ann N Y Acad Sci 2010;1199:90-4.
               35.  Bracken MB. Steroids for acute spinal cord injury. Cochrane Database Syst Rev 2012;1:CD001046.
               36.  Sribnick EA, Wingrave JM, Matzelle DD, Wilford GG, Ray SK, et al. Estrogen attenuated markers of inflammation and decreased
                   lesion volume in acute spinal cord injury in rats. J Neurosci Res 2005;82:283-93.
               37.  Wingrave JM, Schaecher KE, Sribnick EA, Wilford GG, Ray SK, et al. Early induction of secondary injury factors causing activation of
                   calpain and mitochondria-mediated neuronal apoptosis following spinal cord injury in rats. J Neurosci Res 2003;73:95-104.
               38.  Mazzone GL, Nistri A. Delayed neuroprotection by riluzole against excitotoxic damage evoked by kainate on rat organotypic spinal
                   cord cultures. Neuroscience 2011;190:318-27.
               39.  Rong W, Wang J, Liu X, Jiang L, Wei F, et al. 17 beta-estradiol attenuates neural cell apoptosis through inhibition of JNK
                   phosphorylation in SCI rats and excitotoxicity induced by glutamate in vitro. Int J Neurosci 2012;122:381-7.
   34   35   36   37   38   39   40   41   42   43   44